Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Family Planning Methods Among Women in Assuit Egypt

NCT07464067 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-06
Last updated
2026-03-11

Condition(s) studied

Family Planning

Study summary

1. To assess the knowledge , attitude and practices of different types of family planning method among women of reproductive age group, and their correlation with socidemographic and socioeconomic factors .
2. To identify the reasons which withhold the practices of contraceptive methods .
3. To provide baseline information that may help in improving family planning education and counseling services.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
49 Years
Healthy volunteers
No
Inclusion Criteria: * Married women aged between ( 18- 49 ) . * Attending antenatal care (ANC) at selected health facilities. * Willing to give informed consent Exclusion Criteria: * Women with known psychiatric or cognitive impairments affecting judgment.. * Women outside the reproductive age range (\<18 or \>49 years). * Women who refuse to give consent or withdraw during the study

Primary outcome measure(s)

  • -Questionnaire to evaluate the overall knowledge, perceptions, and actual use of family planning methods among married women in the selected areas of Egypt — through study completion, an average of 1 year
    Questionnaire between married women aged 18-49 years

Trial sites (1)

FacilityCityRegionStatus
Assuit University Hospital Asyut Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07464067 on ClinicalTrials.gov ↗ ← All trials in Egypt